Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rezular in IBS-D
NCT00552565Phase 3Completed
- Sponsor
- AGI Therapeutics plc
- Start
- Sep 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexverapamil in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by AGI Therapeutics plc. Started Sep 2007; status: completed.
02
Drugs
dexverapamil
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00552565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552565.